SICCARDI, ANTONIO
SICCARDI, ANTONIO
DIPARTIMENTO DI BIOLOGIA E GENETICA PER LE SCIENZE MEDICHE (attivo dal 01/11/1983 al 26/04/2012)
NMR interaction studies of Neu5Ac-α-(2,6)-Gal-β-(1-4)-GlcNAc with influenza-virus hemagglutinin expressed in transfected human cells
2018 F. Vasile, F. Gubinelli, M. Panigada, E. Soprana, A. Siccardi, D. Potenza
A Combined NMR-Computational Study of the Interaction between Influenza Virus Hemagglutinin and Sialic Derivatives from Human and Avian Receptors on the Surface of Transfected Cells
2018 F. Vasile, M. Panigada, A. Siccardi, D. Potenza, G. Tiana
IMMUNOSURVEILLANCE OF TUMORS: IGE AS A NEW PLAYER
2017 E.A. Nigro, L.M. Ferreira, G. Achatz-Straussberger, A. Ambrosi, F. Sanvito, A.G. Siccardi, L. Vangelista, A.T. Brini
An antitumor cellular vaccine based on a mini-membrane IgE
2012 E.A. Nigro, E. Soprana, A.T. Brini, A. Ambrosi, V.A. Yenagi, D. Dombrowicz, A.G. Siccardi, L. Vangelista
Joint production of prime/boost pairs of Fowlpox Virus and Modified Vaccinia Ankara recombinants carrying the same transgene
2011 E. Soprana, M.R. Panigada, M. Knauf, A. Radaelli, L. Vigevani, A. Palini, C. Villa, M. Malnati, G. Cassina, R. Kurth, S. Norley, A. Siccardi
HLA-C is necessary for optimal human immunodeficiency virus type 1 infection of human peripheral blood CD4 lymphocytes
2010 M. Baroni, A. Matucci, G. Scarlatti, E. Soprana, P. Rossolillo, L. Lopalco, D. Zipeto, A. Siccardi, C. De Santis
The combination of marker gene swapping and fluorescence-activated cell sorting improves the efficiency of recombinant modified vaccinia virus Ankara vaccine production for human use
2010 G. Di Lullo, E. Soprana, M. Panigada, A. Palini, A. Agresti, C. Comunian, A. Milani, I. Capua, V. Erfle, A.G. Siccardi
Antitumor IgE adjuvanticity : key role of Fc epsilon RI
2009 E.A. Nigro, A.T. Brini, E. Soprana, A. Ambrosi, D. Dombrowicz, A. Siccardi, L. Vangelista
Marker gene swapping facilitates recombinant Modified Vaccinia Virus Ankara production by host-range selection
2009 G. Di Lullo, E. Soprana, M. Panigada, A. Palini, V. Erfle, C. Staib, G. Sutter, A.G. Siccardi
AllergoOncology : the role of IgE-mediated allergy in cancer
2008 E. Jensen-Jarolim, G. Achatz, M.C. Turner, S. Karagiannis, F. Legrand, M. Capron, M.L. Penichet, J.A. Rodríguez, A. Siccardi, L. Vangelista, A.B. Riemer, H. Gould
Hedgehogs, humans and high-school science : the benefits of involving high-school students in university research
2008 G. Pavesi, A. Siccardi, G. Viale, C. Grazioli, T. Calciolari, M.L.G. Tenchini, P. Plevani
HLA-C increases HIV-1 infectivity and is associated with gp120
2008 A. Matucci, P. Rossolillo, M. Baroni, A. Siccardi, A. Beretta, D. Zipeto
IgE present powerful activity in anti-tumor vaccination
2007 E.A. Nigro, A.T. Brini, G. Achatz, L. Vangelista, A.G. Siccardi
NKG2D-independent suppression of T cell proliferation by H60 and MICA
2005 A.K. Kriegeskorte, F.E. Gebhardt, S. Porcellini, M. Schiemann, C. Stemberger, T.J. Franz, K.M. Huster, L.N. Carayannopoulos, W.M. Yokoyama, M. Colonna, A.G. Siccardi, S. Bauer, D.H. Busch
T-cell engineering by a chimeric T-cell receptor with antibody-type specificity for the HIV-1 gp120
2005 S. Masiero, C. Del Vecchio, R. Gavioli, G. Mattiuzzo, M.G. Cusi, L. Micheli, F. Gennari, A. Siccardi, W.A. Marasco, G. Palu, C. Parolin
Membrane IgE binds and activates Fc epsilon RI in an antigen-independent manner
2005 L. Vangelista, E. Soprana, M. Cesco-Gaspere, P. Mandiola, G. Di Lullo, R.N. Fucci, F. Codazzi, A. Palini, G. Paganelli, O.R. Burrone, A.G. Siccardi
Induction of murine mucosal CCR5-reactive antibodies as an anti-human immunodeficiency virus strategy
2005 C. Barassi, E. Soprana, C. Pastori, R. Longhi, E. Buratti, F. Lillo, C. Marenzi, A. Lazzarin, A.G. Siccardi, L. Lopalco
Improved thymopoietic potential in aviremic HIV-infected individuals treated with HAART by intermittent IL-2 administration
2003 S. Porcellini, G. Vallanti, S. Nozza, G. Poli, A. Lazzarin, G. Tambussi, A.G. Siccardi, F. Grassi
CCR5-reactive antibodies in seronegative partners of HIV-seropositive individuals down-modulate surface CCR5 in vivo and neutralize the infectivity of R5 strains of HIV-1 In vitro
2000 L. Lopalco, C. Barassi, C. Pastori, R. Longhi, S.E. Burastero, G. Tambussi, F. Mazzotta, A. Lazzarin, M. Clerici, A.G. Siccardi
HIV neutralizing IgA in exposed seronegative subjects recognise an epitope within the gp41 coiled-coil pocket
2000 C. Pastori, C. Barassi, S. Piconi, R. Longhi, M.L. Villa, A.G. Siccardi, M. Clerici, L. Lopalco